Mylan Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?
MYLAN LABS LTD has seventy-two approved drugs.
There are nine tentative approvals on MYLAN LABS LTD drugs.
Summary for Mylan Labs Ltd
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 72 |
Drugs and US Patents for Mylan Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 091554-001 | Sep 19, 2011 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Labs Ltd | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 203800-001 | May 19, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Labs Ltd | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 206608-001 | Jun 8, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Labs Ltd | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 203258-002 | Jul 20, 2018 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
